ZA933567B - Use of (E)-2-(p-fluorophenethyl)-3-fluoroallylamine in the treatment of Alzheimer's disease - Google Patents

Use of (E)-2-(p-fluorophenethyl)-3-fluoroallylamine in the treatment of Alzheimer's disease

Info

Publication number
ZA933567B
ZA933567B ZA933567A ZA933567A ZA933567B ZA 933567 B ZA933567 B ZA 933567B ZA 933567 A ZA933567 A ZA 933567A ZA 933567 A ZA933567 A ZA 933567A ZA 933567 B ZA933567 B ZA 933567B
Authority
ZA
South Africa
Prior art keywords
fluoroallylamine
fluorophenethyl
alzheimer
disease
treatment
Prior art date
Application number
ZA933567A
Other languages
English (en)
Inventor
Ian A Mcdonald
Michael G Palfreyman
Original Assignee
Merrell Dow Pharma
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Merrell Dow Pharma filed Critical Merrell Dow Pharma
Publication of ZA933567B publication Critical patent/ZA933567B/xx

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/13—Amines
    • A61K31/135—Amines having aromatic rings, e.g. ketamine, nortriptyline
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia

Landscapes

  • Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical & Material Sciences (AREA)
  • Neurosurgery (AREA)
  • Neurology (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biomedical Technology (AREA)
  • Organic Chemistry (AREA)
  • Hospice & Palliative Care (AREA)
  • Psychiatry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
ZA933567A 1992-05-27 1993-05-21 Use of (E)-2-(p-fluorophenethyl)-3-fluoroallylamine in the treatment of Alzheimer's disease ZA933567B (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US88867192A 1992-05-27 1992-05-27

Publications (1)

Publication Number Publication Date
ZA933567B true ZA933567B (en) 1993-12-13

Family

ID=25393634

Family Applications (1)

Application Number Title Priority Date Filing Date
ZA933567A ZA933567B (en) 1992-05-27 1993-05-21 Use of (E)-2-(p-fluorophenethyl)-3-fluoroallylamine in the treatment of Alzheimer's disease

Country Status (15)

Country Link
EP (1) EP0642338B1 (de)
JP (1) JPH07507299A (de)
KR (1) KR950701518A (de)
AT (1) ATE147978T1 (de)
AU (1) AU672401B2 (de)
CA (1) CA2135752C (de)
DE (1) DE69307702T2 (de)
DK (1) DK0642338T3 (de)
ES (1) ES2101311T3 (de)
GR (1) GR3022608T3 (de)
HU (1) HUT72316A (de)
MX (1) MX9303074A (de)
NO (1) NO944524D0 (de)
WO (1) WO1993024120A1 (de)
ZA (1) ZA933567B (de)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA2172605A1 (en) * 1993-09-24 1995-03-30 Ian A. Mcdonald Transdermal device containing (e)-2-(p-fluorophenethyl)-3-fluoroallylamine for the treatment of alzheimer's disease
US5488188A (en) * 1994-09-29 1996-01-30 Merrell Dow Pharmaceuticals Inc. Process for the preparation of (E)-1-amino-2-(fluoromethylene)-4-(p-fluorophenyl)butane, novel processes for preparing an intermediate thereof, and novel intermediates thereof
US5599986A (en) * 1994-09-29 1997-02-04 Hoechst Marion Roussel Inc. Process for the preparation of alkali metal salts of diformylamide
US20070293548A1 (en) * 2006-03-31 2007-12-20 Wang Eric Y Inhibitors of semicarbazide-sensitive amine oxidase (SSAO) and VAP-1 mediated adhesion useful for treatment and prevention of diseases
EP1870097A1 (de) * 2006-06-15 2007-12-26 Newron Pharmaceuticals S.p.A. Alpha-aminoamidederivate zur Behandlung von kognitiven Störungen

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
NZ224982A (en) * 1987-06-16 1990-08-28 Merrell Dow Pharma E-2-(p-fluorophenethyl)-3-fluoroallylamine and its pharmaceutical compositions

Also Published As

Publication number Publication date
CA2135752A1 (en) 1993-12-09
NO944524L (no) 1994-11-25
NO944524D0 (no) 1994-11-25
MX9303074A (es) 1994-01-31
KR950701518A (ko) 1995-04-28
ES2101311T3 (es) 1997-07-01
ATE147978T1 (de) 1997-02-15
AU3978293A (en) 1993-12-30
HUT72316A (en) 1996-04-29
JPH07507299A (ja) 1995-08-10
EP0642338B1 (de) 1997-01-22
WO1993024120A1 (en) 1993-12-09
HU9403384D0 (en) 1995-02-28
DE69307702D1 (de) 1997-03-06
CA2135752C (en) 1998-07-14
DE69307702T2 (de) 1997-05-28
GR3022608T3 (en) 1997-05-31
DK0642338T3 (da) 1997-02-10
AU672401B2 (en) 1996-10-03
EP0642338A1 (de) 1995-03-15

Similar Documents

Publication Publication Date Title
GR3029670T3 (en) Treatment of macular degeneration.
ZA9410041B (en) Use of PLA2 inhibitors as treatment for Alzheimer's Disease
EP0541686A4 (en) Tachykinin agonists for treatment of alzheimer's disease
GB2285219A (en) Use of norastemizole for the treatment of allergic disorders
IL86423A0 (en) Pharmaceutical compositions for the treatment of alzheimer's disease
MY118526A (en) Method for improving the pharmacokinetics of tipranavir
ES2136167T3 (es) Composiciones de idebenona para tratar la enfermedad de alzheimer.
PL338673A1 (en) Application of fanquinone in treating alzheimer disease
IL117695A0 (en) Pharmaceutical agents for the treatment of alzheimer's disease
GR3022608T3 (en) USE OF (E)-2-(p-FLUOROPHENETHYL)-3-FLUOROALLYLAMINE IN THE TREATEMENT OF ALZHEIMER'S DISEASE.
ZA924128B (en) New combination preparations for treatment of Parkinson's disease.
GR3036260T3 (en) Use of olanzapine for the manufacture of a medicament for the treatment of cerebral focal ischemia
NO961180L (no) Transdermal anordning inneholdende (E)-2-(p-fluorfenetyl)-3-fluorallylamin for behandling av Alzheimers sykdom
FI953725L (fi) Ornitiiniaminotransferaasi-inhibiittorien käyttö lääkeaineen valmistamiseksi Alzheimerin taudin hoitamiseksi
LV5179A3 (lv) Preparats "etoksidins" teju kunga un zarnu slimibu profilaksei un arstesanai
GB9109887D0 (en) Pharmaceutical formulations for the treatment of peripheral vascular diseases
SI0664121T1 (en) Use of raloxifene and its analogs for the manufacture of a medicament for the treatment of atherosclerose and ischaemic heart disease